Guangdong Zhongsheng Pharmaceutical Co (SZSE:002317) YoY EBITDA Growth : 56.96% (As of Mar. 2025)

View and export this data going back to 2009. Start your Free Trial

What is Guangdong Zhongsheng Pharmaceutical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Guangdong Zhongsheng Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 56.96%.

Guangdong Zhongsheng Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.12.

Guangdong Zhongsheng Pharmaceutical Co YoY EBITDA Growth Historical Data

The historical data trend for Guangdong Zhongsheng Pharmaceutical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Zhongsheng Pharmaceutical Co YoY EBITDA Growth Chart

Guangdong Zhongsheng Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-140.31

332.31

11.26

-18.30

-140.80

Guangdong Zhongsheng Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															-62.20	-50.46	7.41	-2,534.78	56.96

Guangdong Zhongsheng Pharmaceutical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Guangdong Zhongsheng Pharmaceutical Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-0.224	-	0.549)	/	\| 0.549 \|
=	-140.80 %

Guangdong Zhongsheng Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(0.124	-	0.079)	/	\| 0.079 \|
=	56.96 %

Guangdong Zhongsheng Pharmaceutical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Guangdong Zhongsheng Pharmaceutical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Zhongsheng Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

Xihu Industrial Zone, Information Industry Park, Shilong Town, Guangdong Province, Dongguan, CHN, 523325

Website

http://www.zspcl.com

Guangdong Zhongsheng Pharmaceutical Co Ltd is engaged in the pharmaceutical business. It is involved in the research and development, production and sales of pharmaceuticals, the cultivation of medicinal materials, and the processing of medicinal herbs, chemical raw material synthesis, and pharmaceutical trade.

Executives

Chen Yong Hong	Directors, executives
Zhao Xi Ping	Executives
Zhou Xue Li	Director
Zhang Yu Chong	Secretary, Director
Yin Yuan Yuan	Executives
Li Su Xian	Supervisors
Long Chun Hua	Directors, executives
Ding Chen Huan	Supervisors
Li Tao	Executives
Cao Jia Yue	Supervisors
Zhang Shao Ri	Director
Ye Hui Tang	Director
Long Chao Feng	Directors, executives
Sun Xian Peng	Independent director
Huang Shi Bin	Supervisors

Guangdong Zhongsheng Pharmaceutical Co Headlines

No Headlines